Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy

European Journal of Pharmacology

Volumn 424, Issue 3, 2001, Pages 179-187

  Alcock, Shelda J ^a   Hemsley, Kim M ^a   Crocker, Ann D ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Anticholinergic drug; Antipsychotic drug; Catalepsy; Receptor occupancy; Striatum; Ventral

Indexed keywords

ATROPINE; DOPAMINE 2 RECEPTOR; MUSCARINIC RECEPTOR; RACLOPRIDE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BINDING SITE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; SUBSTANTIA NIGRA;

ANIMALS; ATROPINE; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN; CATALEPSY; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MUSCARINIC ANTAGONISTS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC; SUBSTANTIA NIGRA;

EID: 0035958722     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01146-3     Document Type: Article

References (42)

1. Interactions between striatal acetylcholine and dopamine receptors in motor control
2. Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour
3. A survey of drug-induced extrapyramidal reactions
4. 125I]-iodosulpiride
5. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum
6. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist
7. Representation of the body by single neurons in the dorsal striatum of the awake, unrestrained rat
8. Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate putamen
9. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents in the caudate-putamen, globus pallidus and substantia nigra of rat brain
10. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
11. Localization of striatal muscarinic receptors involved in dopamine receptor-mediated behavioural responses
12. Raclopride-induced increases in muscle rigidity in the rat are ameliorated following muscarinic cholinergic receptor antagonism in the ventral striatum
13. Evidence that a nigral GABAergic-cholinergic balance controls posture
14. Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone
15. Cholinergic-anticholinergic antagonism in parkinsonism
16. Effects of regional striatal lesions on motor, motivational and executive aspects of progressive ratio performance in rats
17. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: Relation to extrapyramidal side effects
18. On stereotypy and catalepsy: Studies on the effect of amphetamines and neuroleptics in rats
19. Activation of midbrain presumed dopaminergic neurons by muscarinic cholinergic receptors: An in vivo electrophysiological study in the rat
20. Prediction of drug-induced catalepsy based on dopamine D1, D2 and muscarinic acetylcholine receptor occupancies
21. The effects of an irreversible dopamine receptor antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), on the regulation of muscle tone in the rat: The role of the substantia nigra
22. Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: Relationship with D2 dopamine receptor occupancy
23. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra
24. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability
25. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal depletion: Possible relation to parkinsonian symptoms
26. Activation of muscarinic receptors stimulates GABA release in the rat globus pallidus
27. Drug effects on active immobility responses: What they tell us about neurotransmitter systems and motor functions
28. The organization of the projection from the cerebral cortex to the striatum in the rat
29. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism
30. 2-receptor antagonists induce catalepsy via different efferent striatal pathways
31. 2 dopamine receptors in neuroleptic catalepsy
32. Possible role of opiate receptors and des-tyrosine1-gamma-endorphin in schizophrenia
33. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors
34. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects
35. Central effects of anticholinergic drugs measured by the apomorphine gnawing test in mice
36. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography
37. Antipsychotic doses and neuroleptic/dopamine receptors
38. Antischizophrenic drugs and brain cholinergic receptors
39. Drugs to treat extrapyramidal side effects
40. Dopaminergic and cholinergic interaction in cataleptic responses in mice
41. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats